Falling drug prices and high inventory in the United States present new hurdles for Indian manufacturers. By Keerthi Ramesh India’s pharmaceutical sector reached a historic milestone this fiscal year with
exports climbing to a record $31.1 billion. While the figure marks a significant
achievement for the “pharmacy of the world” a closer look at the American market
reveals a shifting landscape of pricing pressures and stockpiled supplies that are…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.